Posted on Oct 23, 2023
University of Missouri researchers get $1.2 million to study how to treat combat wound infections...
430
8
2
5
5
0
Posted 7 mo ago
Responses: 2
PO1 William "Chip" Nagel
"“The goal is to try to find the optimal regiment of a delivery approach, so that we can treat a wounded infection by those really bad bugs,” Sun said. “Hopefully, we can also minimize the side effects caused by the antibiotic treatment.”
Sun and her team will study different dosage regimens using micro-mist fusion technology. The portable device was initially designed to apply skin care products. Sun noticed the device had the potential to do more. The portable device allows the antibiotic to penetrate the wound without causing damage.
“You don’t need a lot of training to be able to use the device,” Sun said. “So, they can treat the wounded people on the side. And this technology can be incorporated at all levels of wound care like in a nursing home when you are treating a patient with a chronic wound.”
Once the first phase of research is finished, Sun said the goal is to get approval from the FDA for human trials. The grant lasts until August 2026."
"“The goal is to try to find the optimal regiment of a delivery approach, so that we can treat a wounded infection by those really bad bugs,” Sun said. “Hopefully, we can also minimize the side effects caused by the antibiotic treatment.”
Sun and her team will study different dosage regimens using micro-mist fusion technology. The portable device was initially designed to apply skin care products. Sun noticed the device had the potential to do more. The portable device allows the antibiotic to penetrate the wound without causing damage.
“You don’t need a lot of training to be able to use the device,” Sun said. “So, they can treat the wounded people on the side. And this technology can be incorporated at all levels of wound care like in a nursing home when you are treating a patient with a chronic wound.”
Once the first phase of research is finished, Sun said the goal is to get approval from the FDA for human trials. The grant lasts until August 2026."
(2)
(0)
Read This Next